- Medical School - Texas Tech University Health Sciences Center (2000-2004)
- Fellowship - University of California, Los Angeles (2007-2010), Pediatric Hematology/oncology
- Residency - University of California, Los Angeles (2004-2007), Pediatrics
Tiffany Simms-Waldrip, M.D.
- Pediatrics - Hematology-Oncology
- Pediatric hematology-oncology
- Hematopoietic stem cell transplant
Biography
Tiffany Simms-Waldrip, M.D., is an Associate Professor in the Department of Pediatrics at UT Southwestern Medical Center. She specializes in pediatric hematology-oncology and focuses her research on hematopoietic stem cell transplant, transplant for bone marrow failure syndromes, and graft-versus-host disease.
Dr. Simms-Waldrip earned her medical degree at Texas Tech University Health Sciences Center. She performed her residency in pediatrics at UCLA Medical Center, where she also completed a fellowship in pediatric hematology-oncology.
Certified by the American Board of Pediatrics in pediatric hematology-oncology, she joined the UT Southwestern faculty in 2010.
Dr. Simms-Waldrip is the Clinical Director of Pediatric Hematopoietic Stem Cell Transplant (HSCT) at UT Southwestern and Children’s Medical Center Dallas. She also serves as the HSCT Education Coordinator and HSCT Bone Marrow Failure Physician at both institutions.
She is a member of the American Society for Transplantation and Cellular Therapy and serves on numerous committees, including as Chair of the Tissue and Transfusion Utilization Committee at Children’s. In addition, she is a Pediatrics Residency Program mentor at UTSW.
She has published numerous academic articles.
Education & Training
Professional Associations & Affiliations
- American Society for Transplantation and Cellular Therapy
Honors & Awards
- Clinical Research Training Scholar 2011, American Society of Blood and Marrow Transplantation
- NIH T32 Developmental Hematology Training Grant 2008-2011, National Institutes of Health
- AAP Resident Research Grant 2006, American Academy of Pediatrics
- Magna Cum Laude 2000, Texas Christian University
Books & Publications
-
Publications
-
Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes.
Zhang-Velten ER, Parsons D, Lee P, Chambers E, Abdulrahman R, Desai NB, Dan T, Wardak Z, Timmerman R, Vusirikala M, Patel P, Simms-Waldrip T, Aquino V, Koh A, Tan J, Iqbal Z, Zhang Y, Reynolds R, Chiu T, Joo M, Hrycushko B, Ouyang L, Lamphier R, Yan Y, Jiang SB, Kumar KA, Gu X, Transplantation and cellular therapy 2021 Nov -
Food for Gut: Microbiota Fuels Immune Reconstitution after BMT.
Simms-Waldrip TR, Koh AY Cell host & microbe 2018 Apr 23 4 423-424 -
Antibiotic-Induced Depletion of Anti-Inflammatory Clostridia is Associated with the Development of GVHD in Pediatric Stem Cell Transplant Patients.
Simms-Waldrip TR, Sunkersett G, Coughlin LA, Savani MR, Arana C, Kim J, Kim M, Zhan X, Greenberg DE, Xie Y, Davies SM, Koh AY Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2017 Feb -
Activation of HIF-1a and LL-37 by commensal bacteria inhibits Candida albicans colonization.
Fan D, Coughlin LA, Neubauer MM, Kim J, Kim MS, Zhan X, Simms-Waldrip TR, Xie Y, Hooper LV, Koh AY Nature medicine 2015 Jun -
Invasive fungal infections in pediatric hematopoietic stem cell transplant patients.
Simms-Waldrip T, Rosen G, Nielsen-Saines K, Ikeda A, Brown B, Moore T Infectious diseases (London, England) 2015 Apr 47 4 218-24 -
Incidence and outcome of rhinovirus in children undergoing hematopoietic stem cell transplantation
DeMasi J, Aquino V, Simms-Waldrip TR, Koh AY, Holmes S. Biology of Blood and Marrow Transplantation 2015 Feb 21 2 S248 -
Nasal Endoscopy in the evaluation of prolonged febrile events in children undergoing hematopoietic stem cell transplantation
Aquino V, Holmes S, Olivarez K, DeMasi J, Simms-Waldrip TR, Koh AY, Siegel J Biology of Blood and Marrow Transplantation 2015 Feb 21 2 S242?S243 -
Dramatic response to rituximab in a child with severe cold autoimmune hemolytic anemia arising after allogeneic hematopoietic SCT.
Simms-Waldrip T, Ikeda A, Goldfinger D, Moore T, Yuan S Bone marrow transplantation 2010 Jan 45 1 201-2 -
The aggresome pathway as a target for therapy in hematologic malignancies.
Simms-Waldrip T, Rodriguez-Gonzalez A, Lin T, Ikeda AK, Fu C, Sakamoto KM Molecular genetics and metabolism 2008 Jul 94 3 283-6 -
Role of the aggresome pathway in cancer: targeting histone deacetylase 6-dependent protein degradation.
Rodriguez-Gonzalez A, Lin T, Ikeda AK, Simms-Waldrip T, Fu C, Sakamoto KM Cancer research 2008 Apr 68 8 2557-60 -
FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia.
Parcells BW, Ikeda AK, Simms-Waldrip T, Moore TB, Sakamoto KM Stem cells (Dayton, Ohio) 2006 May 24 5 1174-84
-
Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes.
Research
- Hematopoietic stem cell transplant
- Transplant for bone marrow failure syndromes
- Graft-versus-host disease
Clinical Focus
- Pediatric hematology-oncology
- Hematopoietic stem cell transplant
- Transplant for bone marrow failure syndromes
- Graft-versus-host disease
Results: 1 Locations
Children's Medical Center of Dallas
1935 Medical District DriveDallas, Texas 75235 214-730-5437 Directions to Children's Medical Center of Dallas